Cargando…

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies

Transarterial chemoembolization (TACE) is a therapeutic option for patients with intermediate‐stage hepatocellular carcinoma (HCC) or metastatic liver cancers. Identifying those patients who particularly benefit from TACE remains challenging. Macrophage migration inhibitory factor (MIF) represents i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wirtz, Theresa H., Loosen, Sven H., Schulze‐Hagen, Max, Gorgulho, Joao, Kandler, Jennis, Joerdens, Markus, Demir, Münevver, Mohr, Raphael, Bruners, Philipp, Kuhl, Christiane, Trautwein, Christian, Berres, Marie‐Luise, Tacke, Frank, Luedde, Tom, Roderburg, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504849/ https://www.ncbi.nlm.nih.gov/pubmed/33787014 http://dx.doi.org/10.1111/cts.13033

Ejemplares similares

Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis
por: Loosen, Sven H, et al.
Publicado: (2021)

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies
por: Loosen, Sven H., et al.
Publicado: (2019)

Skeletal Muscle Composition Predicts Outcome in Critically Ill Patients
por: Loosen, Sven H., et al.
Publicado: (2020)

Antibiotic therapy is associated with an increased incidence of cancer
por: Roderburg, Christoph, et al.
Publicado: (2022)

Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy
por: Loosen, Sven H., et al.
Publicado: (2021)

IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
por: Loosen, Sven H., et al.
Publicado: (2018)

Achalasia is associated with a higher incidence of depression in outpatients in Germany
por: Loosen, Sven H., et al.
Publicado: (2021)

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies
por: Loosen, Sven H., et al.
Publicado: (2023)

Recent Trends and In-Hospital Mortality of Transarterial Chemoembolization (TACE) in Germany: A Systematic Analysis of Hospital Discharge Data between 2010 and 2019
por: Krieg, Sarah, et al.
Publicado: (2022)

Decreased Bone Mineral Density Is a Predictor of Poor Survival in Critically Ill Patients
por: Schulze-Hagen, Maximilian F., et al.
Publicado: (2021)

Current Trends in Inpatient Care and In-Hospital Mortality of Cholangiocarcinoma in Germany: A Systematic Analysis between 2010 and 2019
por: Roderburg, Christoph, et al.
Publicado: (2022)

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma
por: Mohr, Raphael, et al.
Publicado: (2021)

Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC
por: Loosen, Sven H., et al.
Publicado: (2021)

From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
por: Mohr, Raphael, et al.
Publicado: (2021)

An Elevated FIB-4 Score Is Associated with an Increased Incidence of Depression among Outpatients in Germany
por: Schöler, David, et al.
Publicado: (2022)

Prevalence of and factors associated with a treatment delay due to the COVID-19 pandemic in patients with gastrointestinal cancer in Europe
por: Roderburg, Christoph, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
por: Roderburg, Christoph, et al.
Publicado: (2023)

CT-based determination of excessive visceral adipose tissue is associated with an impaired survival in critically ill patients
por: Wirtz, Theresa H., et al.
Publicado: (2021)

The spectrum of comorbidities at the initial diagnosis of heart failure a case control study
por: Loosen, Sven H., et al.
Publicado: (2022)

Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes
por: Loosen, Sven H, et al.
Publicado: (2021)

Digital single-operator cholangioscopy with EHL as salvage therapy of an internalized and stone-impacted biliary stent 13 years after implantation
por: Loosen, Sven H., et al.
Publicado: (2022)

Automated major psoas muscle volumetry in computed tomography using machine learning algorithms
por: Duong, Felix, et al.
Publicado: (2021)

The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis
por: Loosen, Sven H., et al.
Publicado: (2019)

A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019)

Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma
por: Loosen, Sven H., et al.
Publicado: (2020)

Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy
por: Loosen, Sven H., et al.
Publicado: (2021)

Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment
por: Vucur, Mihael, et al.
Publicado: (2018)

Enlarged extracellular vesicles are a negative prognostic factor in patients undergoing TACE for primary or secondary liver cancer–a case series
por: Schöler, David, et al.
Publicado: (2021)

Peripheral blood CD3+HLADR+ cells and associated gut microbiome species predict response and overall survival to immune checkpoint blockade
por: Gorgulho, Joao, et al.
Publicado: (2023)

In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease?
por: Mohr, Raphael, et al.
Publicado: (2020)

Serum Levels of miR-143 Predict Survival in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019)

Circulating MicroRNA-223 Serum Levels Do Not Predict Sepsis or Survival in Patients with Critical Illness
por: Benz, Fabian, et al.
Publicado: (2015)

Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies
por: Roderburg, Christoph, et al.
Publicado: (2020)

The role of the innate immune system in the development and treatment of hepatocellular carcinoma
por: Roderburg, Christoph, et al.
Publicado: (2020)

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015)

Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer
por: Loosen, Sven H., et al.
Publicado: (2019)

Low Myostatin Serum Levels Are Associated with Poor Outcome in Critically Ill Patients
por: Wirtz, Theresa H., et al.
Publicado: (2020)

Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases
por: Loosen, Sven H., et al.
Publicado: (2018)

Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC)
por: Kehmann, Linde, et al.
Publicado: (2023)

Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors
por: Hellberg, Teresa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mmqutjd7seeloddoqqdesh0ige